Adam Keeney
Förmögenhet: 1 M $ per 2026-05-31
Förmögenhet: 1 M $ per 2026-05-31
Adam Keeney is Executive VP & Head-Corporate Development at Biogen, Inc. since 2023.
Formerly, Dr. Keeney was President, Chief Executive Officer & Director at NodThera Ltd. from 2018 to 2022.
Dr. Keeney completed undergraduate studies at the University of Leeds and earned a doctorate from The University of Nottingham.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BIOGEN INC. 0 % | 2026-05-01 | 6 365 ( 0 % ) | 1 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| BIOGEN INC. | Företagsledare/Principal | 2023-04-17 |
| Företag | Position | Slut |
|---|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Verkställande Direktör | 2022-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån